Korsuva is an injectable drug for itching that results from kidney dialysis
Showing 25 of 1716
Oppenheimer's Mark Breidenbach describes the company as an 'overlooked innovator in the cancer diagnostic space'
The biotech entered a licensing agreement with the largest provider of kidney dialysis in the US
The share sale will fund the Connecticut-based firm’s expansion of its antibiotics portfolio
Dr Gregory Smith has become the firm's chief medical cannabis advisor, said Callitas
The Montana-based firm’s new spinal implant is engineered using porous titanium
The Shacklewell Lane Mosque in London will begin accepting crypto donations
The pain killer IV tramadol reduces the pain in patients who undergo bunionectomy surgery
Online lender GreenSky offers quick decisions on home improvement loans and will trade on Nasdaq with ticker 'GSKY'
It also has a strong, diverse economy with a broad base of entrepreneurs
Woloschuk has business development experience with big pharma
Investors took note as these vastly different biotech companies all have innovation in their DNA
The FTSE 100-drugs giant expects product sales, which have been in decline for a while now, to return to growth this year
The FTSE 250-listed generic drugs maker’s CEO Siggi Olafsson, said: "Our efforts to reduce costs across the Group are on track and we continue to focus on enhancing and investing in our pipeline"
Supply, expansion and services agreements are all part of the partnership agreement
Aircastle announced a secondary offering of nearly 8 million shares, sending its stock plummeting
The AIM-listed biopharmaceutical company said the monies raised will be used to fund near-term regulatory and pre-commercial investments for iclaprim, its novel antibiotic candidate, and to strengthen the company's balance sheet
'Welcome to the industry. It’s not going anywhere.' – Meris Kott, chief executive officer, Redfund Capital Corporation.
The group reported further progress on its flagship product, namely FDA approval to sell its VMS Plus machine
The Seattle-based company is hailed for its high-potency cookies and tinctures
Together, the companies will develop new minimally invasive neurosurgical devices
The trial will analyze how effective these vaginal rings are in preventing mobile sperm from reaching the cervical canal during sex
The life-sciences company saw a double-digit revenue increase for the period
The biopharma is developing a drug to treat acromegaly, a pituitary gland disorder
Scientists are optimistic about XEN1101's ability to curb epileptic seizures